Most patients experience only mild and temporary side effects , which are considered part of the bodys natural inflammatory response to the injection
A retrospective analysis of the DURATION trials found that overall, greater weight loss was associated with gastrointestinal adverse events with exenatide once weekly and exenatide twice daily
Moreover, potential issues related to tolerability (gastrointestinal side effects) and the need for injection in non-oral formulations could impact patient adherence compared to conventional oral PAH therapies
BPC-157 or other peptides may yet prove useful for a specific condition, at a specific dose and route of administration
Regarding the secondary endpoint hospitalization due to heart failure, the results of the studies are heterogenous
The statistical significance of differences between the glaucoma group and the control group was determined with the Students t test or Fishers exact test